Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Company profile
Ticker
JSHG
Exchange
Website
CEO
Norman D. Schwartz
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
ABC Acquisition Corp 1501, Bio-Carbon Systems International Inc., Enhanced Energy Solutions Corp.
SEC CIK
Corporate docs
IRS number
270531073
JSHG stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
3 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
31 Mar 22
UPLOAD
Letter from SEC
14 Mar 22
CORRESP
Correspondence with SEC
3 Mar 22
UPLOAD
Letter from SEC
2 Mar 22
UPLOAD
Letter from SEC
31 Jan 22
CORRESP
Correspondence with SEC
21 Jan 22
UPLOAD
Letter from SEC
20 Dec 21
10-Q
2021 Q3
Quarterly report
12 Nov 21
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.08 k | 3.08 k | 3.08 k | 3.08 k | 3.08 k | 3.08 k |
Cash burn (monthly) | (no burn) | 1.01 k | 36.72 k | 82.23 k | 10.80 k | 6.70 k |
Cash used (since last report) | n/a | 24.92 k | 909.52 k | 2.04 mm | 267.57 k | 166.06 k |
Cash remaining | n/a | -21.84 k | -906.43 k | -2.03 mm | -264.48 k | -162.98 k |
Runway (months of cash) | n/a | -21.7 | -24.7 | -24.7 | -24.5 | -24.3 |